New - European Medical Journal

Continue

News

Hematology
17 Mar 2017

Selvita Announces First Patient Dosed in Phase I/II Clinical Trial of SEL24 in Acute Myeloid Leukemia

Kraków, Poland, March 17, 2017 – Selvita (WSE:SLV), a clinical stage drug discovery and development company focused on innovative medicines for patients…
Oncology
17 Mar 2017

Genomic Health Unveils a Wealth of Data for the Oncotype DX® Breast Cancer Test, Reinforcing Its Value in Improving Patient Outcomes and Leading to More Cost-Effective Management

Geneva, Switzerland, March 17, 2017 – Genomic Health today announced the presentation of 15 abstracts for the Oncotype DX® breast cancer test at the 15th…
Hematology
15 Mar 2017

Agena Bioscience Introduces New Lung and Colon Cancer Panels for Detection of Somatic Mutations from Liquid Biopsies and Solid Tumor Tissues

Agena Bioscience today introduced new targeted research panels for the detection of somatic mutations from lung and colon cancers.
Oncology
14 Mar 2017

Cambridge-based Astex Pharmaceuticals Celebrates as Cancer Drug Receives US Marketing Approval

Cambridge, UK, March 13, 2017 – Astex Pharmaceuticals (“Astex”), a pharmaceutical company dedicated to the discovery and development of novel small…
Oncology
13 Mar 2017

Selvita to Present New Data from its Oncology Programs at the Upcoming AACR Annual Meeting 2017

Kraków, Poland, March 13, 2017 – Selvita (WSE:SLV), a clinical stage drug discovery and development company focused on innovative medicines for oncology…
Nephrology
13 Mar 2017

An Association Between Klotho Deficiency and Kidney Function

STRONG links have been discovered between the soluble protein Klotho and the decline in kidney function. The Klotho protein, whose gene is named after…
Nephrology
13 Mar 2017

Model Kidneys Give New Hope to Researchers

AN ANIMAL testing alternative may soon be available after researchers at Bingham University, Binghamton, New York, USA, achieved a breakthrough in the…
Oncology
8 Mar 2017

German Community of Gynecological Oncology (AGO) Acknowledges MammaPrint in Breast Cancer Guidelines as Having Level 1A Clinical Evidence

Irvine, CA, USA and Amsterdam, the Netherlands, March 08, 2017 – Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics…